Status | Study |
RECRUITING |
Study Name: Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) Condition: Polymyalgia Rheumatica Date: 2023-03-06 Interventions: Taken subcutaneously every 4 weeks until Week 48 in combination with a 24-week prednisone taper regimen |
Completed |
Study Name: Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients Condition: Polymyalgia Rheumatica Date: 2022-12-28 Interventions: Other: Blood samples before and after standard of care of polymyalgia rheumaticaBlood samples were taken before glucocorticoid treatment and thr |
Not yet recruiting |
Study Name: Polymyalgia Rheumatica and Giant Cell Arteritis Condition: Polymyalgia Rheumatica Giant Cell Arterit Date: 2016-12-01 Interventions: Other: 18F-FDG PET/CT 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography |
Recruiting |
Study Name: Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE Condition: Polymyalgia Rheumatica Date: 2016-09-16 Interventions: Drug: Tocilizumab 6 Intravenou |
Not yet recruiting |
Study Name: Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica Condition: Polymyalgia Rheumatica Date: 2016-09-08 Interventions: Drug: Sirukumab Sirukumab will |
Completed |
Study Name: Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica Condition: Polymyalgia Rheumatica Date: 2016-08-26 Interventions: Drug: tocilizumab 3 monthly IV infusions in PMR patients |
Recruiting |
Study Name: Biomarkers in Giant Cells Arteritis Condition: Giant Cells Arteritis Date: 2016-07-20 Interventions: Behavioral: Clinical evaluation |
Not yet recruiting |
Study Name: Giant Cell Arteritis and Anakinra Trial Condition: Giant Cell Arteritis Date: 2016-07-05 Interventions: Drug: PLACEBO Other Name: comp |
Recruiting |
Study Name: Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease Condition: Horton's Disease Date: 2016-06-29 Interventions: Biological: Blood samples |
Terminated |
Study Name: Delayed Release Prednisone in PMR Condition: Polymyalgia Rheumatica Date: 2016-02-18 Interventions: Drug: Delayed-Release (DR) Prednisone |